Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Assess Structural Damage in Rheumatoid Arthritis Using Biomarkers and Radiography

ClinicalTrials.gov ID: NCT01476956

Public ClinicalTrials.gov record NCT01476956. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:36 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Prospective Validation of Soluble Biomarkers as Predictors of Structural Damage in Rheumatoid Arthritis

Study identification

NCT ID
NCT01476956
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
CARE ARTHRITIS LTD.
Industry
Enrollment
571 participants

Conditions and interventions

Interventions

  • Observational study Other

Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2011
Primary completion
Dec 30, 2017
Completion
Dec 30, 2019
Last update posted
Oct 26, 2021

2011 – 2019

United States locations

U.S. sites
5
U.S. states
3
U.S. cities
4
Facility City State ZIP Site status
Johns Hopkins Arthritis Center, Johns Hopkins University Baltimore Maryland 21224
Rheumatologist Hospital for Special Surgery New York New York 10021
Division of Rheumatology, Columbia University, College of Physicians and Surgeons New York New York 10032
Division of Allergy, Immunology and Rheumatology, University of Rochester Rochester New York 14642
Seattle Rheumatology Associates Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01476956, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 26, 2021 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01476956 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →